Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

Why Moderna’s COVID-19 vaccine trial hit a snag

By Brian Buntz | October 22, 2020

Moderna Logo (PRNewsFoto/Moderna Therapeutics)

Moderna’s COVID-19 vaccine clinical trial has hit a roadblock. Moderna (NSDQ:MRNA) learned that contractors it had hired failed to recruit sufficient numbers of minorities for the 30,000-person study, according to a Reuters report.

The lack of Black, Latinos and Native American patients led the company to tap academic researchers with ties to diverse communities.

Moderna didn’t not immediately respond to a request for comment from Drug Discovery & Development.

As of September 17, African Americans comprised 7% of trial participants, yet the make-up roughly the proportion of the U.S. population is 13%.

The company announced on October 22 that its trial was fully enrolled its trial, with 30,000 participants — 37% of which are minorities.

According to the CDC, COVID-19 disproportionately affects several ethnic groups. African Americans, for instance, are 2.6 times more likely to contract the virus than non-Hispanic whites.

Moderna is making progress in recruiting minorities. As of October 16, 2020, roughly 36% of cumulatively enrolled trial participants enrolled hailed from minority communities.

Tell Us What You Think! Cancel reply

Related Articles Read More >

AstraZeneca-Oxford
Study finds AstraZeneca COVID-19 vaccine could be effective against Brazil variant
RCSB Protein Data Bank now has more than 1,000 SARS-CoV-2 proteins
Data sciencea
Q&A: Keys to unlock data science potential for drug discovery
Ivermectin not supported for mild COVID-19, study says

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards